Diary - News
All news ORPHELIA Pharma raises 4 m€ to fund its commercial operations and clinical developments
French family offices join as new shareholders and Board members
Paris and Lyon, January 28th , 2020 – ORPHELIA Pharma, a French biopharmaceutical company dedicated to the development and marketing of paediatric drugs in the fields of oncology and neurology, announces it has raised 4 million € in December 2019. The proceeds will be used to grow the company’s team, develop its commercial and clinical infrastructure and advance its projects.
